 | Up a level |
2019
Michels, Sebastian, Massuti, Bartomeu, Schildhaus, Hans-Ulrich, Franklin, Jeremy 
ORCID: 0000-0003-1536-0925, Sebastian, Martin, Felip, Enriqueta, Grohe, Christian, Rodriguez-Abreu, Delvys, Abdulla, Diana S. Y., Bischoff, Helge, Brandts, Christian, Carcereny, Enric, Corral, Jesus, Dingemans, Anne-Marie C., Pereira, Eva, Fassunke, Jana, Fischer, Rieke N., Gardizi, Masyar, Heukamp, Lukas ORCID: 0000-0002-3388-3482, Insa, Amelia, Kron, Anna, Menon, Roopika, Persigehl, Thorsten, Reck, Martin, Riedel, Richard, Rothschild, Sacha I., Scheel, Andreas H., Scheffler, Matthias, Schmalz, Petra, Smit, Egbert F., Limburg, Meike, Provencio, Mariano, Karachaliou, Niki, Merkelbach-Bruse, Sabine, Hellmich, Martin, Nogova, Lucia, Buettner, Reinhard, Rosell, Rafael and Wolf, Juergen
(2019).
Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial.
J. Thorac. Oncol., 14 (7).
S. 1266 - 1277.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1556-1380
2017
Michels, Sebastian, Gardizi, Masyar, Schmalz, Petra, Thurat, Meike, Pereira, Eva, Sebastian, Martin, Carcereny, Enric, Corral, Jesus, Paz-Ares, Luis, Felip, Enriqueta, Grohe, Christian, Rodriguez Abreu, Delvys, Insa Molla, Amelia, Bischoff, Helge, Reck, Martin, Karachaliou, Niki, Scheel, Andreas, Brandes, Vanessa, Rieke, Fischer, Nogova, Lucia, Scheffler, Matthias, Franklin, Jeremy, Hellmich, Martin, Massuti, Bartomeu, Buettner, Reinhard, Rosell, Rafael and Wolf, Juergen (2017). EUCROSS: A European Phase II Trial of Crizotinib in Advanced Adenocarcinoma of the Lung Harboring ROS1 Rearrangements - Preliminary Results. J. Thorac. Oncol., 12 (1). S. S379 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380